Cargando...
Role of Novel Oral Anticoagulants in the Treatment of Antiphospholipid Syndrome
Background: Antiphospholipid syndrome (APS) is an autoimmune disease characterized by thrombosis or pregnancy loss with persistent positive antibodies. Standard treatment for APS with history of thromboembolism is heparin or low-molecular-weight heparin followed by a vitamin K antagonist (VKA). Nove...
Gardado en:
| Publicado en: | Hosp Pharm |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Thomas Land Publishers, Inc.
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5080995/ https://ncbi.nlm.nih.gov/pubmed/27803506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hpj5109-759 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|